OLIN ($OLN) is expected to release its quarterly earnings data on Thursday, January 29th after market close, per Finnhub. Analysts are expecting revenue of $1,566,483,527 and earnings of -$0.64 per share.
You can see Quiver Quantitative's $OLN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
OLIN Insider Trading Activity
OLIN insiders have traded $OLN stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $OLN stock by insiders over the last 6 months:
- MARC EHRHARDT (VP & Pres Corp Development) purchased 20,000 shares for an estimated $373,956
- TERESA M VERMILLION (VP & Treasurer) has made 0 purchases and 2 sales selling 10,500 shares for an estimated $220,492.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OLIN Revenue
OLIN had revenues of $1.7B in Q3 2025. This is an increase of 7.78% from the same period in the prior year.
You can track OLN financials on Quiver Quantitative's OLN stock page.
OLIN Hedge Fund Activity
We have seen 182 institutional investors add shares of OLIN stock to their portfolio, and 187 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ILEX CAPITAL PARTNERS (UK) LLP removed 2,488,402 shares (-99.0%) from their portfolio in Q3 2025, for an estimated $62,185,165
- MILLENNIUM MANAGEMENT LLC added 2,272,877 shares (+1063.0%) to their portfolio in Q3 2025, for an estimated $56,799,196
- FMR LLC removed 1,753,874 shares (-56.3%) from their portfolio in Q3 2025, for an estimated $43,829,311
- THRIVENT FINANCIAL FOR LUTHERANS added 1,619,696 shares (+8127.7%) to their portfolio in Q3 2025, for an estimated $40,476,203
- SEMPER AUGUSTUS INVESTMENTS GROUP LLC added 1,126,809 shares (+141.3%) to their portfolio in Q3 2025, for an estimated $28,158,956
- AMUNDI added 941,697 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,533,008
- UBS GROUP AG removed 904,123 shares (-55.6%) from their portfolio in Q3 2025, for an estimated $22,594,033
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
OLIN Government Contracts
We have seen $707,348,757 of award payments to $OLN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- AWARD FY25 PRODUCTION ORDERS.: $505,793,773
- NGSW FACILITY CONSTRUCTION SOW AT LCAAP UCO.: $136,728,416
- THE PURPOSE OF THIS DELIVERY ORDER IS TO AWARD THE XM1201 ONE-WAY LUMINESCENT (OWL) TRACER MANUFACTURING PR...: $29,651,468
- INSTALLATION OF FIRE PROTECTION SYSTEMS IN THE AREAS OF THE AMMUNITION MANUFACTURING BUILDINGS 1, 2 & 3 THA...: $14,562,750
- 9MM FRANGIBLE AMMUNITION: $4,924,420
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
OLIN Analyst Ratings
Wall Street analysts have issued reports on $OLN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 10/29/2025
To track analyst ratings and price targets for OLIN, check out Quiver Quantitative's $OLN forecast page.
OLIN Price Targets
Multiple analysts have issued price targets for $OLN recently. We have seen 7 analysts offer price targets for $OLN in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Peter Osterland from Truist Securities set a target price of $23.0 on 01/21/2026
- Arun Viswanathan from RBC Capital set a target price of $24.0 on 01/16/2026
- Patrick Cunningham from Citigroup set a target price of $24.0 on 01/13/2026
- Aleksey Yefremov from Keybanc set a target price of $29.0 on 10/29/2025
- Joshua Spector from UBS set a target price of $22.0 on 10/29/2025
- Michael Sison from Wells Fargo set a target price of $22.0 on 10/29/2025
- Steve Byrne from B of A Securities set a target price of $30.0 on 10/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
